🧬 Biotech

A perfect couple: Chromium keeps ruthenium grounded in water electrolysis

Researchers report chromium keeps ruthenium grounded in water electrolysis, a finding relevant to catalyst chemistry.

Type 1 diabetes breakthrough offers hope for WA children

A type 1 diabetes breakthrough is reported to offer hope for children in Western Australia.

Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

A report that a novel CRISPR-based gene therapy is poised to become the first approved to alter genes inside the body.

How one family gave a critical boost to gene therapy research

A family affected by Sanfilippo syndrome raised millions of dollars to support gene therapy research.

A CRISPR gene boost reduces seizures and strengthens muscles in mice

Research reports that a CRISPR-based gene boost reduced seizures and strengthened muscles in mice.

STAT+: Gene therapy’s long-debated cancer risk materializes

Gene therapy's long-debated cancer risk has materialized, according to STAT reporting on viral vector findings.

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

Novartis reports seven previously unknown tumor cases possibly linked to its SMA gene therapy.

STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down

A nonprofit is reviving a gene therapy that a startup had shelved after the company shut down.

How does CRISPR gene editing work, in plain words?

The article explains how CRISPR gene editing works in simple terms.

Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design

This research focuses on using generative methods for drug design to address recent advances in gene therapy.

Claude may have found a new CRISPR-like gene editing system

How SwarmRSI Cut Drug Discovery From 6 Months to 3 Weeks – The AI Revolution You Can’t Miss

SwarmRSI has significantly accelerated drug discovery to just three weeks using AI.

Gene Therapy Cuts Severe Infections 93% In A Rare Immune Disease

Gene therapy significantly reduced severe infections in patients with Wiskott-Aldrich syndrome by 93%.

Anthropic Expands Claude’s Life Sciences Ecosystem for Drug Discovery Workflows

Anthropic is expanding Claude's role in life sciences, connecting it to drug discovery workflows.

Silent bacterial genes yield potential leads for future cancer drugs

Research finds silent bacterial genes may yield natural-product leads for future cancer drugs.

Epileptic seizures nearly vanish after people receive experimental gene therapy in their brains

Experimental gene therapy delivered to the brain has nearly eliminated epileptic seizures in some patients.

A Startup Says a Claude AI Agent Chose a Gene Therapy and Injected It Into a Mouse’s Brain

A startup reports that a Claude AI agent selected a gene therapy and guided its injection into a mouse brain.

Anthropic bought a one-person, AI-powered biotech: is this drug discovery’s future?

Anthropic acquired a small AI-driven biotech company focused on drug discovery, raising questions about the future of the field.

DrugCoding: A Scientific Programming Agent for Drug Discovery

DrugCoding presents a scientific programming agent aimed at drug discovery workflows.

The iPS Cell Breakthroughs Reshaping Drug Discovery for Rare Disease

Nippon.com reports on iPS cell breakthroughs reshaping drug discovery for rare diseases.

The Next Healthcare Gold Rush? CMS Opens the Door to Cell and Gene Therapy

CMS is opening the door to cell and gene therapy in healthcare payment, which could create a new market.

Warp Sciences emerges from stealth, to apply robotics to drug research

Warp Sciences exits stealth with funding and founders from OpenAI and Meta to apply robotics to drug research.

New control theory framework proposes a safer approach to aging drug discovery. 'Existing aging theories describe what changes with age but do not prescribe how to intervene.'

A new control theory framework aims to provide safer approaches to aging drug discovery.

DeepMind Built an Agent for Drug Discovery. The Hard Part Is Still the Structure.

Google DeepMind published work on an agentic cheminformatics system for drug discovery and discusses the remaining structural challenges.

Genetic Therapy For Treatment Of Devastating Neurological Disease: Prader-Willi Syndrome

Reports a study reactivating silenced genes in Prader-Willi patient-derived cells as a potential genetic therapy.

Gene therapy that led to boy’s death had limited efficacy

Nature reports that a gene therapy linked to a boy's death had limited efficacy.

Beyond Connected Data: How AI Is Transforming Pharmaceutical Intelligence, Drug Discovery and…

AI is being applied to pharmaceutical intelligence, drug discovery, and data connectivity across the industry.

Spatial Biology: The Technology That Could Redefine Aging, Peptides, and Regenerative Medicine

Spatial biology techniques that map individual cells in their tissue context are discussed as a tool for studying aging and regenerative medicine.

Scientists demonstrate AI-designed enzyme for drug synthesis

Researchers report an AI-designed enzyme created with the RFD4-Proteina generative protein design model, used for drug synthesis.

Sea cucumber-inspired gel could help heal damaged tissue in humans. Waterloo researchers develop a new material that supports tissue regeneration, with promising results in preclinical studies...

Researchers have developed a new gel inspired by sea cucumbers that shows promise in tissue regeneration.

Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation

Researchers discovered a drug originally developed for spinal cord injury that repairs DNA damage and reduces brain inflammation in Alzheimer's models.

An AI Agent Injected Drugs Into a Live Mouse’s Brain

Researchers reportedly used an AI agent to inject gene therapy into a live mouse brain.

Unravelling DNA repair: uOttawa-led team shows how cells protect their genetic blueprint

Researchers at the University of Ottawa have revealed how cells protect their genetic blueprint through DNA repair mechanisms.

STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories

Novo Nordisk's anti-inflammatory drug failed, but cardiologists say they will still pursue anti-inflammatory approaches to heart disease.

Gene editing could replace a lifetime of medication, but there's a catch

A single gene-editing treatment could potentially protect against heart disease and high cholesterol, though a significant caveat remains.

Cancer-selective gene circuits via intrinsic ribosomal frameshifting

Research presents cancer-selective gene circuits built with intrinsic ribosomal frameshifting.

Light-emitting nanoparticles help ultrasound direct gene editing to selected mouse brain regions

Light-emitting nanoparticles combined with ultrasound allow precise gene editing in selected mouse brain regions.

STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down

STAT reports that Artiva is shutting down after two deaths in an autoimmune cell therapy trial.

STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer

A Phase 3 trial of a Merck and Kelun-Biotech targeted drug reduced the risk of death by about one-third in advanced endometrial cancer.

A quick squeeze helps CRISPR turn skin cells into neurons more efficiently

Phys.org reports that applying a brief squeeze to cells makes CRISPR conversion of skin cells into neurons more efficient.

STAT+: Alnylam says Huntington’s drug shows promise in early study

Alnylam reports early study results suggesting its Huntington's disease drug shows promise, though it remains unclear whether it will slow progression.

Nature’s Deadliest Killer Isn’t Even Alive: Turning to CRISPR to Survive the Prion Spillover

The article discusses using CRISPR technology to combat prion diseases.

ESULAB Logo Design | Biotechnology & Clean Tech Brand Identity

The article discusses the brand identity and logo design for a biotechnology and clean tech brand focused on environmental solutions.

What If We Could Rewrite Our Genes to Create Medicines? The Future of Genetic Engineering

The article discusses the potential future of genetic engineering in creating medicines that could go beyond treating symptoms.

Common osteoporosis drugs linked to 24% lower dementia risk in major study

A large study links common osteoporosis drugs to a 24% lower risk of dementia in older adults.

Scientists trick cancer cells into making the drugs that kill them

Scientists developed a cancer-fighting strategy that tricks cancer cells into producing the drugs that kill them.

Technique that spots tRNAs in action could accelerate drug development for inherited diseases

Researchers report a technique for spotting tRNAs in action that could speed drug development for inherited diseases.

Customizable DNA labels can selectively guide drug carriers to cancer cells

Researchers report customizable DNA labels that can selectively guide drug carriers to cancer cells.

STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study

Eli Lilly reports that its investigational triple-agonist drug retatrutide outperformed Ozempic in a head-to-head study.

Experimental treatment promotes repair after heart attack damage in animal study: « Scientists have developed a treatment that promotes the regeneration of damaged heart muscle following a heart attack. »

Scientists report an experimental treatment that promotes regeneration of damaged heart muscle after a heart attack in animal studies.